Literature DB >> 24344910

Sexual dimorphism in ALS: exploring gender-specific neuroimaging signatures.

Peter Bede1, Marwa Elamin, Susan Byrne, Orla Hardiman.   

Abstract

Our objective was to explore neuroanatomical differences between female and male ALS patients in the context of sexual dimorphism in healthy controls. Fourteen female ALS patients, 13 male ALS patients, 22 healthy male controls and 20 healthy female controls were recruited into a comprehensive neuroimaging study. Cortical thickness measurements and diffusion tensor imaging (DTI) were utilized to explore gender-specific anatomical vulnerability. DTI analysis across all study groups revealed higher fractional anisotropy in association with male gender in the brainstem, cerebellum, fornix, thalamus, anterior forceps and corticospinal tracts accounting for diagnosis and age. While females showed a trend of higher age-adjusted cortical thickness in the right parieto-occipital and left mid-frontal regions, males demonstrated higher cortical thickness in the left lingual and left superior temporal regions, accounting for diagnosis. Significant multifocal white matter differences have also been identified between healthy male and female controls. In conclusion, sexual dimorphism is an overlooked and potentially confounding factor in admixed ALS neuroimaging studies. Our results suggest that gender is an additional dimension of disease heterogeneity in ALS. Given the significant pre- and post-morbid gender differences, we feel that ALS imaging studies should be controlled for gender or, alternatively, single gender studies should be considered.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; MRI; gender; neuroimaging; phenotypic heterogeneity

Mesh:

Year:  2013        PMID: 24344910     DOI: 10.3109/21678421.2013.865749

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  26 in total

Review 1.  Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria.

Authors:  Michael J Strong; Sharon Abrahams; Laura H Goldstein; Susan Woolley; Paula Mclaughlin; Julie Snowden; Eneida Mioshi; Angie Roberts-South; Michael Benatar; Tibor HortobáGyi; Jeffrey Rosenfeld; Vincenzo Silani; Paul G Ince; Martin R Turner
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2017-01-05       Impact factor: 4.092

Review 2.  Cerebellar pathology in motor neuron disease: neuroplasticity and neurodegeneration.

Authors:  Rangariroyashe H Chipika; Grainne Mulkerrin; Pierre-François Pradat; Aizuri Murad; Fabrice Ango; Cédric Raoul; Peter Bede
Journal:  Neural Regen Res       Date:  2022-11       Impact factor: 6.058

3.  Cortical synaptic and dendritic spine abnormalities in a presymptomatic TDP-43 model of amyotrophic lateral sclerosis.

Authors:  Matthew J Fogarty; Paul M Klenowski; John D Lee; Joy R Drieberg-Thompson; Selena E Bartlett; Shyuan T Ngo; Massimo A Hilliard; Mark C Bellingham; Peter G Noakes
Journal:  Sci Rep       Date:  2016-11-29       Impact factor: 4.379

4.  Development of an Automated MRI-Based Diagnostic Protocol for Amyotrophic Lateral Sclerosis Using Disease-Specific Pathognomonic Features: A Quantitative Disease-State Classification Study.

Authors:  Christina Schuster; Orla Hardiman; Peter Bede
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

5.  Adiponectin levels in the serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients: possible influence on neuroinflammation?

Authors:  Patrizia Bossolasco; Raffaella Cancello; Alberto Doretti; Claudia Morelli; Vincenzo Silani; Lidia Cova
Journal:  J Neuroinflammation       Date:  2017-04-20       Impact factor: 8.322

6.  Survival prediction in Amyotrophic lateral sclerosis based on MRI measures and clinical characteristics.

Authors:  Christina Schuster; Orla Hardiman; Peter Bede
Journal:  BMC Neurol       Date:  2017-04-17       Impact factor: 2.474

Review 7.  Implications of white matter damage in amyotrophic lateral sclerosis (Review).

Authors:  Ting Zhou; Tina Khorshid Ahmad; Kiana Gozda; Jessica Truong; Jiming Kong; Michael Namaka
Journal:  Mol Med Rep       Date:  2017-08-07       Impact factor: 2.952

8.  Cortical progression patterns in individual ALS patients across multiple timepoints: a mosaic-based approach for clinical use.

Authors:  Marlene Tahedl; Rangariroyashe H Chipika; Jasmin Lope; Stacey Li Hi Shing; Orla Hardiman; Peter Bede
Journal:  J Neurol       Date:  2021-01-05       Impact factor: 4.849

9.  The clinical and radiological profile of primary lateral sclerosis: a population-based study.

Authors:  Eoin Finegan; Rangariroyashe H Chipika; Stacey Li Hi Shing; Mark A Doherty; Jennifer C Hengeveld; Alice Vajda; Colette Donaghy; Russell L McLaughlin; Niall Pender; Orla Hardiman; Peter Bede
Journal:  J Neurol       Date:  2019-07-19       Impact factor: 4.849

Review 10.  Lessons of ALS imaging: Pitfalls and future directions - A critical review.

Authors:  Peter Bede; Orla Hardiman
Journal:  Neuroimage Clin       Date:  2014-02-27       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.